Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00383318 · ClinicalTrials.gov registry record
Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 450
- Enrollment target
NCT00383318 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 450 participants.
The verdict
NCT00383318 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the demographic, metabolic, and genomic characteristics of patients who develop severe hyperbilirubinemia to patients who never developed a significant bilirubin level.
Interventions
- PROCEDURE Gene mutation sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00383318
The ClinicalTrials.gov registry entry for NCT00383318 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gene mutation sample is the first listed.
NCT00383318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00383318 about?
NCT00383318 is a clinical study titled "Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia". The purpose of this study is to compare the demographic, metabolic, and genomic characteristics of patients who develop severe hyperbilirubinemia to patients who never developed a significant bilirubin level.
What is the current status of trial NCT00383318?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2006-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00383318?
The interventions under investigation include: Gene mutation sample (PROCEDURE).
Who is sponsoring clinical trial NCT00383318?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.